Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
CN¥7.00 - CN¥10.88
Next Earnings Date
Apr 30 2025
Next Earnings Date
Apr 30 2025
Last Price
Market Cap | CN¥14.47B |
EV | CN¥14.59B |
Shares Outstanding | 1.93B |
Beta | 0.24 |
Analyst Rating | BUY |
Analyst Target Price | CN¥10.53 |
P/E 2025E | 18.47x |
P/Revenue 2025E | 5.21x |
Revenue | -15.00% |
EPS | - |
Operating Cash Flow | -26.00% |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 76.51% |
Net Profit Margin 2025E | 25.39% |
ROE 2025E | 10.16% |
ROCE 2024 | -0.63% |
DPS 2025E | CN¥0.18 |
Payout Ratio 2025E | 43.90% |
Div. Yield 2025E | 2.41% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Tonghua Dongbao Pharmaceutical Co., Ltd.
600867
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Chun, Sheng Leng
Employees
3,196
Website
www.thdb.comIPO Date
1994-08-24
Headquarters
Dongbao New Village, Tonghua County, Tonghua, Jilin Province, 134123, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved